|
Mobile version
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FDA approves $93K prostate cancer vaccine USA TODAY Share     The Food and Drug Administration on April 29 approved the first vaccine to treat prostate cancer -- or any cancer -- the culmination of decades of research into harnessing the immune system to fight tumors. The $93,000 vaccine, Provenge, doesn't prevent cancer, unlike the polio shot or recently approved vaccines that block infection with viruses that cause most cervical tumors. Provenge also doesn't cure cancer. More
Injection of melanin nanoparticles could make human body radiation-resistant Popular Science Share
One of the major downsides of radiation therapy, which commonly is used to shrink cancerous tumors, is its harmful effect on normal cells. Now, thanks to research done by scientists at the Albert Einstein College of Medicine of Yeshiva University, doctors someday may use melanin-covered nanoparticles to administer higher doses of radiation to cancerous cells without compromising the healthy ones. More Study: Immune cells predict success of head, neck cancer treatment University of Michigan Health System Share
 Levels of a key type of
immune cell are higher in head and neck cancer patients whose tumors are linked to the human papillomavirus, according to researchers at the University of Michigan Comprehensive Cancer Center. The finding suggests a way to predict which tumors are most likely to respond to chemotherapy and radiation and allow doctors to choose the best treatment option up front.
More
Enzyme found to be predictive marker of survival in head, neck cancer PhysOrg.com Share
Most treatment for advanced head and neck cancer requires chemotherapy with a drug called cisplatin. A substantial number of patients do not respond well to this therapy, but oncologists are unable to prescribe alternative agents because they don't know which patients will respond to platinum therapy. However, new research from Fox Chase Cancer Center suggests that levels of ERCC1 offer a predictive marker of survival in squamous carcinoma of the head and neck. More
How IBM's world community grid is helping cure AIDS, cancer, world hunger Fast Company Share
For the past four years, Lauren Moran has devoted herself to groundbreaking cancer research, chronicling the fickle interaction between molecules and proteins. Despite having a full-time job -- "stat geek" on the New York Yankees' media relations staff -- Moran screens drug candidates daily. And continuously. She conducts experiments while talking on the phone to her parents, attending games at Yankee Stadium and watching episodes of "The Office" in her Bronx apartment. Even in the dead of night. More Gaps in insurance policies make oral drugs too pricey for some cancer patients The Washington Post Share
When Jere Carpentier learned last year that she had advanced colon cancer -- her third malignancy in a dozen years -- she worried about spending hours in a clinic tethered to an intravenous line, enduring punishing chemotherapy that would make her hair fall out. Her veins ruined by earlier treatments, Carpentier was elated when her oncologist said this time she could avoid needles and take a pill at home that specifically would target the cancer cells and spare her hair. More
Oral, throat cancers can be silent killers Dentistry IQ Share
This year, more than 35,000 people in the United States will receive a diagnose of oral or pharyngeal cancer, and according to the Oral Cancer Foundation nearly half of will die within five years. In recognition of Oral, Head and Neck Cancer Awareness Week, which took place in mid-April, Dr. Steven Sobol, an otolaryngologist working out of the ENTA practice on the Decatur Memorial Hospital campus, addressed the topic. More
Candy-like tobacco products: Poisoning is not only risk U.S. News & World Report Share
Tobacco products that look and taste like candy, and have poisoned thousands of children who mistake them for sweet treats, are just the latest in a long line of tobacco goods that appeal to children. The threat they pose to children is not only poisoning but an increased risk of addiction. Smokeless tobacco products
poisoned 1,768 children younger than age 6 between 2006 and 2008, researchers at the Harvard School of Public Health
recently reported in Pediatrics.
More
Waxman calls for baseball ban on smokeless tobacco Bloomberg BusinessWeek Share
Major League Baseball should ban players from using smokeless tobacco in dugouts and on the field because of its health risks and influence on children, said Rep. Henry Waxman, chairman of the House Committee on Energy and Commerce. "Millions of young fans are exposed on a daily basis to the use of smokeless tobacco by their heroes," Waxman, a California Democrat, said recently at a hearing in Washington. More |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
